{"timestamp": 1771602514.770574, "value": {"ticker": "ARTL", "company_name": "Artelo Biosciences, Inc.", "short_name": "Artelo Biosciences, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 3443604, "float_shares": 2009197, "shares_outstanding": 2311144, "short_ratio": 1.27, "short_percent_of_float": 0.0594, "shares_short": 110410, "shares_short_prior": 48967, "insider_percent_held": 0.0047299997, "institution_percent_held": 0.04044, "total_cash": 1720000, "total_debt": 954000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0, "current_ratio": 0.376, "book_value": -0.407, "price_to_book": -3.6609337, "operating_cashflow": -8176000, "free_cashflow": -3466125, "price": 1.49, "52w_high": 28.6, "52w_low": 1.15, "avg_volume": 490765, "avg_volume_10d": 28320, "full_time_employees": 6, "audit_risk": 0, "overall_risk": 0}}